Systematic evaluation on the treatment of diabetic nephropathy with Tao Hong Si Wu Decoction and its modified prescription
10.3760/cma.j.issn.1673-4246.2012.04.003
- VernacularTitle:桃红四物汤及其加减方治疗糖尿病肾病的随机对照系统评价
- Author:
Zhenxi PIAO
;
Zhicheng QU
;
Qiwei SUN
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathy;
Tao Hong Si Wu decoction;
System review;
Meta-analysis
- From:
International Journal of Traditional Chinese Medicine
2012;34(4):295-298
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effectiveness and safety of Tao Hong Si Wu decoction in treating Diabetic nephropathy (DN).Methods Randomized controlled trials (RCTs) on Tao Hong Si Wu decoction in treatment of DN were searched in PubMed,EMbase,Cochrane Library,CMCC,VIP,CNKI,CBM.Data were strictly extracted using the fundamental evaluation method recommended in Cochrane Handbook and Meta-analysis was performed using RevMan 5.0.24 software.Results Eleven RCTs of 956 patients of DN were analyzed.The content and methodological quality of these 11 test samples were low,which could not be undertaken high quality research of sensitivity analysis.Meta-analysis results showed that:Tao Hong Si Wu decoction could be reduced to some extent,the early and clinical stage of DN patients with 24 h UPE reduce the Ⅲ,Ⅳ of Scr,and improve renal function to a certain extent.The results also showed that Tao Hong Si Wu decoction could lower TG and CHO,better control FBG and HbAlc of DN patients,besides,serious adverse reactions have not been found during the treatment.Conclusion Tao Hong Si Wu Decoction could be a relatively safe and effective treatment of DN drugs.However,a high probability of selection bias and measurement bias in the included studies was bound to affect the strength of the results.
